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Parasitic diseases, such as sleeping sickness, Chagas disease and malaria,
remain a major cause of morbidity and mortality worldwide, but particu-
larly in tropical, developing countries. Controlling these diseases requires
a better understanding of host–parasite interactions, including a deep
appreciation of parasite distribution in the host. The preferred accumulation
of parasites in some tissues of the host has been known for many years, but
recent technical advances have allowed a more systematic analysis and
quantifications of such tissue tropisms. The functional consequences of
tissue tropism remain poorly studied, although it has been associated with
important aspects of disease, including transmission enhancement, treat-
ment failure, relapse and clinical outcome. Here, we discuss current
knowledge of tissue tropism in Trypanosoma infections in mammals, describe
potential mechanisms of tissue entry, comparatively discuss relevant find-
ings from other parasitology fields where tissue tropism has been
extensively investigated, and reflect on new questions raised by recent dis-
coveries and their potential impact on clinical treatment and disease
control strategies.1. Introduction
Tropism is the ability of an organism to specifically interact with another cell or
orient itself towards a given stimulus. One of the most famous examples is
phototropism in which plants orient part of their organism towards the Sun
[1]. Parasites also show tropism, which can happen to different degrees and
at different levels: host, tissue, cell and, for intracellular pathogens, subcellular
compartment. For example, at the host level, Trypanosoma brucei gambiense and
Trypanosoma brucei rhodesiense can infect humans, while Trypanosoma congolense
and Trypanosoma vivax cannot. Within a host, tissue tropism can change during
the course of infection. For example, acute Toxoplasma gondii infections are
associated with gut cell invasion and pathology, whereas chronic disease is
characterized by brain invasion and neurological impairment.
In most cases, the reasons underlying tissue choice by a pathogen remain
poorly understood, but are probably multifactorial. Nonetheless, tissue tropism
can have a direct impact on the parasite life cycle. For instance, it may promote
its persistence in the host and amplify transmission potential. The same tissue
can also allow parasites to follow two possible fates, as exemplified by Plasmo-
dium vivax, which can either replicate from one to tens of thousands of parasites
in a single hepatocyte during the liver stage of infection or it can enter a quies-
cent state and remain undetected for several months/years (reviewed in [2]).
These biological decisions have enormous repercussions for disease progression
at the individual level, and for disease epidemiology at a community level.
In this review, we focus on tissue tropism of pathogenic Trypanosoma
species, namely salivarian (African) trypanosomes and the stercorarian (Amer-
ican) trypanosomes, and will draw comparisons with other parasites, where
relevant. These organisms are clinically in humans and animals [3]. Chagas dis-
ease (T. cruzi) currently affects 5–18 million people in the Americas, directly
causing 10 000 deaths annually [4]. The prevalence of sleeping sickness
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Figure 1. Life cycle of trypanosomes. (a) African trypanosomes (T. brucei, T. congolense and T. vivax): a tsetse takes a bloodmeal on an infected mammal and
becomes a vector of African trypanosomiasis. Procyclic forms establish in the midgut by clonal expansion. The parasites travel to the proventriculus, salivary glands
and/or proboscis, where they become epimastigotes and then infective metacyclics. In the following bloodmeal, the fly injects some of these parasites into the
mammalian host, through its saliva. Parasites in the tissues (dermis, hypodermis) enter the bloodstream as metacyclic trypomastigotes and differentiate to blood-
stream forms. Tissues affected by each parasite species are also depicted in the figure. T. vivax bloodstream forms can also be mechanically transmitted by non-tsetse
vectors to new mammalian hosts, without biological differentiation. (b) Trypanosoma cruzi: a triatomine bug feeds on an infected mammalian host and becomes a
vector of Chagas disease. Trypomastigotes establish in the midgut, where they differentiate into epimastigotes and multiply. Epimastigotes travel to the hindgut and
differentiate into infective metacyclic trypomastigotes. In the following bloodmeal, the triatomine releases the infective metacyclic trypomastigotes in its faeces in
the skin near the bite site. Trypomastigotes enter the mammalian host via mucosal membranes and invade cells, where they differentiate into intracellular amas-
tigotes. These intracellular forms continue to multiply until they differentiate back into trypomastigotes, which burst out of the cell and are released into the
bloodstream, reaching a variety of tissues. This figure was modified from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Generic License.
https://smart.servier.com.
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2(T. brucei gambiense and T. brucei rhodesiense) is declining fast
to less than 20 000 cases owing to continued surveillance and
control strategies, but 65 million people remain at risk in 36
countries of sub-Saharan Africa [5]. Nagana (T. brucei
brucei, T. congolense, T. vivax), surra (T. evansi) and dourine
(T. equiperdum) are a major and growing threat for livestock
welfare and production in Africa, Asia and Latin America
[5,6].
In this review, we will revisit forgotten literature describ-
ing where these protozoan parasites preferentially locate and
how this localization relates to disease pathogenesis, and we
will integrate this knowledge with more recent studies tack-
ling the mechanisms and selective advantages of tissue
tropism. We will provide an overview of (i) how tissue trop-
ism features in the life cycles of trypanosomes; (ii) the various
tissue reservoirs of each species; (iii) the known and potential
mechanisms of tissue tropism; (iv) its advantages for the
parasite; and (v) how tropism influences organ-specific path-
ology. In §7, we reflect on future perspectives for Trypanosoma
tissue tropism research and on the potential impact that
research in this area can have for clinical treatment and
transmission control strategy design.2. Tissue tropism in parasite life cycles
African trypanosomes (T. brucei spp., T. congolense, T. vivax)
alternate between the tsetse vector and a wide range of mam-
malian hosts. When the insect vector feeds on an infected
host, trypanosomes are ingested in the blood and colonize
the midgut as procyclic forms (figure 1a). Procyclic parasitesmigrate anteriorly towards the salivary glands (T. brucei) or
the proboscis (T. congolense), where they differentiate into epi-
mastigotes and metacyclic forms. T. vivax does not have a
procyclic stage, colonizing only the mouthparts of the fly.
Metacyclic forms are infective to mammals and get trans-
mitted in the tsetse saliva during a bloodmeal. Once in the
mammalian host, trypanosomes replicate extracellularly in
the bloodstream and may invade tissues or sequester to
their microcirculation. They have been reported in the vascu-
lature and/or tissues of the skin, adipose tissue, gonads,
kidney, adrenal gland, brain, spleen, liver, skeletal muscle,
lung and heart, as well as in the lymph, cerebrospinal fluid
(CSF), and aqueous humour of the eye, which is the liquid
responsible, among other functions, for maintaining the intra-
ocular pressure and providing nutrition to the ocular tissues
that lack blood supply (figure 1a).
Trypanosoma cruzi alternates between the triatomine bug
and the mammalian host (figure 1b). When a triatomine bug
feeds on an infected host, trypomastigotes differentiate into
epimastigotes in the midgut, where they multiply. Sub-
sequently, they migrate to the hindgut, differentiating into
infective metacyclic trypomastigotes. At the next bloodmeal,
the triatomine bug releases trypomastigotes in its faeces in
the skin near the bite site, facilitating trypanosome entry into
the mucosal membranes. At the entry site, trypomastigotes
invade cells, where they differentiate into intracellular amasti-
gotes. Still in the cell, amastigotes multiply and differentiate
again into trypomastigotes. These are released into the blood-
stream, reaching a variety of tissues, including the heart, the
colon, the spleen, the liver, the bladder, the placenta, the
brain and the adipose tissue (figure 1b), where they can
Table 1. Summary of tissue involvement in Trypanosoma infections.
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3infect many cell types. Inside these cells, trypomastigotes
differentiate again into intracellular amastigotes and restart
the cycle. Once in the bloodstream, trypomastigotes can be
transmitted to a new triatomine bug during a bloodmeal.
We can see that tissue tropism is a crucial part of parasite
development, but it is not just an intermittent feature of the
life cycle. In fact, it actually associates with key clinical
phenotypes. In trypanosome infections, parasite invasion of
the central nervous system (CNS) defines the encephalitic,
secondary stage of the disease, characterized by sleep dis-
turbances and psychiatric, motor and sensory malfunctions
that ultimately result in cerebral oedema, coma, systemic
organ failure and death. Cachexia may be linked to adipose
tissue colonization and the parasite lipid metabolism.
T. vivax infections sporadically progress to a haemorrhagic
syndrome [7], a fulminating, invariably fatal disease, charac-
terized by extremely high blood parasitaemia, systemic
haemorrhagic lesions and parasite extravasation to virtually
all organs. In T. cruzi infections, parasite invasion of
cardiomyocytes is the cause of Chagasic cardiomyopathy, a
chronic disease that affects one-third of infected patients
and results in heart failure, ventricular arrhythmias and
cardiovascular and pulmonary pathology [8].3. Tissue reservoirs of parasites
In this section, we will discuss tissue colonization by trypano-
somes. Table 1 highlights the most important aspects ofTrypanosoma tissue tropism that can be extrapolated from
the current body of knowledge.
3.1. Trypanosoma brucei
Trypanosoma brucei is by far the best characterized African try-
panosome. The vast body of animal studies and the shortage
of autopsy reports of human patients have given us a more
detailed knowledge on the localization of parasites in the tis-
sues of experimental animals than in humans. Yet, all
infected mammals share the same pattern of disease pro-
gression based on clinical features. The first sign of
infection is typically at the tsetse bite site, where a chancre
appears as a result of a local immune response against the
injected parasites [9,10]. Yet, the injected saliva and para-
site-derived factors modulate the skin microenvironment to
allow for parasite multiplication and development (reviewed
in [11]). The skin was recently described as a significant reser-
voir during the infection time course [12,13]. The importance
of this reservoir rests on its anatomical relevance for trans-
mission amplification, potentially explaining the persistence
of active foci despite all eradication efforts [14]. Parasites
were found in the dermis, the adipose tissue of the hypoder-
mis and the fascia beneath the panniculus carnosus muscle of
infected mice [12]. Interestingly, dermal viable parasites
tightly interact with the adipocytes in the connective tissue,
suggesting that the parasites might be metabolically benefit-
ing from these interactions [13]. The current view is that
there is a subpopulation of parasites colonizing the skin,
royalsocietypublishing.org/journal/rsob
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4while others migrate to and from the lymphatic and blood
systems. From the blood, parasites can disseminate to several
organs.
Parasite entry to the brain marks the beginning of clinical
stage 2 of the disease, characterized by neurological signs,
including personality changes, sleep disturbances, paralysis
and progressive dementia. The first reports of this phenom-
enon showed the presence of parasites in the CSF [15]
because the parasites had crossed the blood–CSF barrier
[16]. Further crossing of the blood–brain barrier (BBB) has
been supported by imaging studies of human brains where
several lesions suggest the presence of parasites within the
brain parenchyma. The cortical regions, cerebellum and
brain stem are the most severely affected areas [10], showing
evidence for meningoencephalitis [10,17], gliosis [18], haem-
orrhages [19] and subcortical perivascular demyelination
[20]. In infected animals, the lesion pattern presents some
variations. For instance, donkeys infected with T. brucei and
cattle infected with T. rhodesiense showed lesions similar to
those in humans [21,22], while dogs infected with T. brucei
presented more severe lesions in the choroid plexus and pitu-
itary gland [23] and rats infected with T. gambiense failed to
show demyelination [17,24]. All of these might contribute to
the neuropsychiatric disorders typical of this stage of the disease
[25].
Trypanosoma brucei has for a long time been considered a
tissue parasite, so its presence in several other organs comes
as no surprise. Histopathology reports suggest that T. brucei
can be found in most major organs, often associated with
lesions (reviewed in [26] and [27]). The skin and CNS, dis-
cussed above, and the heart, testes and adipose tissue are
the best characterized reservoirs to date [23,28–31].
The presence of trypanosomes in the heart has been
associated with a clinical diagnosis of pancarditis in both
humans [32,33] and experimental animals [33,34]. Myocar-
ditis and epicarditis in hearts of dogs experimentally
infected with T. brucei has also been reported [23]. The pro-
cess of heart invasion by parasites is still controversial.
Invasion through the mural endocardium has been proposed,
but invasion through the vascular endothelium cannot be dis-
carded. Once parasites reach the heart, they target all cardiac
layers, but preferentially the epicardium and endocardium,
culminating in massive disruption of these structures. This
colonization process is accompanied by a marked inflamma-
tory response driven by macrophages, plasma cells and
lymphocytes, with rare giant or foam cells [35]. As the disease
progresses, degeneration of the heart muscle fibres may be
observed. Parasites also colonize the heart valves and the
coronary vessels. However, in these structures, no evidence
for major inflammation was observed [33]. Altogether, these
alterations could be the origin of ventricular dysfunction
and heart failure, especially upon drug treatment [36,37].
The colonization of the reproductive organs by trypano-
somes is well documented in experimentally infected mice
[29,38,39]. Male deer mice infected with T. brucei showed
marked changes in their testes, namely reduced weight,
diameter and thickness of the seminiferous tubules as well
as epididymitis. Histopathological analysis revealed severe
degeneration of seminiferous tubules with reduced numbers
of spermatozoa, spermatids (usually becoming giant cells)
and spermatocytes, hypertrophy of the Sertoli cells and
shrinking of myoid cells. Trypanosome accumulation was
observed solely in the intertubular space, within and outsidethe blood vessels, and lymphatic system, with no parasites
observed beyond the basal laminae of the seminiferous
tubules. Parasite presence is accompanied by orchitis and is
characterized by recruitment of lymphocytes, plasma cells
and macrophages [38]. More recently, Carvalho et al. [39] cor-
roborated and characterized the diagnosis of epididymitis in
experimentally infected mice. In this study, the authors
observed parasites in the blood vessels and in the stroma of
the epididymis, with no invasion of the epididymal ducts.
In the chronic stage of the disease, most of the parasites of
the stromal compartment showed changes consistent with
cell death. An active immune response was also mounted
with numerous macrophages and moderate numbers of
T-lymphocytes observed in the stromal compartment. In
some cases, multifocal rupture of the epididymal ducts was
also visible. These alterations led to the release of spermato-
zoa into the stroma and formation of sperm granulomas.
They could potentially allow for parasite entry into the
ducts and consequent sexual transmission of the disease.
Altogether, orchitis and epididymitis may explain the cases
of infertility observed in infected animals [40,41].
Finally, our group has identified the adipose tissue as a
new reservoir in experimental infections of T. brucei brucei
[31]. T. brucei invades the fat tissue early in infection and per-
sists throughout the chronic phase, where total numbers
account for roughly 10-fold more parasites than the blood.
It is likely that T. brucei gambiense also colonizes the adipose
tissue. Indeed, the luciferase signal of real-time ex vivo biolu-
minescence imaging of stomach, kidneys, heart, liver and
intestines of infected BALB/c mice was reported to be lost
upon visceral fat dissection [28]. We did not find any reports
about the detection of parasites in adipose tissue depots in
humans, but it is likely that this tissue was neglected in the
few autopsies made of patients with sleeping sickness. Inter-
estingly, cachexia is a hallmark of trypanosomiasis (see
below), so it is tempting to hypothesize that fat tropism
and cachexia are linked. Yet, this awaits further investigation.
Importantly, we showed that parasites residing in the fat
are functionally different from those in the blood. Transcrip-
tomic analysis of adipose-tissue forms showed that parasites
probably sense their environment and respond by upregulat-
ing expression of several metabolism-related genes. We
confirmed that parasites in the fat are capable of catabolizing
abundant fatty acids such as myristate, while their blood-
stream counterparts cannot [31]. The fact that parasites in
fat and blood are different was completely unexpected and
raises the question of the population variability in the
whole body and throughout time. Parasite heterogeneity
across tissues raises important concerns for drug treatment
and tells us that there is still a dark side of the parasite’s
life cycle that needs further investigation.
3.2. Trypanosoma congolense
The current knowledge is that T. congolense stays mainly in
the circulating blood and rarely invades tissues. In early
studies, T. congolense has been described as fully intravascular
[42–44]. Yet, Fiennes [45] reported T. congolense parasites to
be evenly distributed in the tissues of lymph nodes, adrenal
cortex and in the anterior pituitary glands. Lesions in the
adrenal glands have subsequently been described as cortex
enlargement and cytoplasmic atrophy [46]. Additionally,
Luckins & Gray [47] have presented light and electron
royalsocietypublishing.org/journal/rsob
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5micrographs showing T. congolense persisting and proliferat-
ing in the connective tissue underlying the site of the tsetse
bite. They showed a growing parasite population for up to
19 days post inoculation, with parasites distributing longitud-
inally through the bundles of collagen, coupled with
infiltration of mononuclear cells in the dermis [47]. This
was further corroborated by Emery & Moloo [48], who also
observed parasites swimming through the collagen fibres
and fluid (oedema) for at least 15 days post bite.
Trypanosoma congolense infections in calves cause enlarge-
ment of the major organs, particularly liver, spleen, kidneys,
heart and lungs, with significant changes in weight from
seven weeks post infection [49]. The choroid plexus of the
brain is often enlarged, and, as infection progresses, so are
the lymph nodes (although this expansion is accompanied
by a reduced cellular density) [46]. Additionally, there is
thickening of the lobular septa and alveolar walls, pulmonary
vasodilation, an up to five times increase in pericardial fluid,
atrophy of the thymic cortex [46] and general decrease in visc-
eral fat [49]. The spleen is enlarged, often associated with
parasite colonization [50]. The enlargement of the heart
derives from an increase in density and size of myocardial
nuclei, and some fibre atrophy. Unlike lesions caused by
T. vivax, necrotic foci have been reported only sporadically
in T. congolense infections [46,50].
Importantly, T. congolense parasites sequester to the
microcirculation of the heart at times of absent blood parasi-
taemia, often in clusters [50,51]. Parasites have also been
reported in the microcirculation of the brain and skeletal
muscle [51]. Cerebral lesions and/or sequestered parasites
have been shown not only in cattle, but also in lions, gazelles
and hartebeests [52]. Despite the lack of evidence for free
T. congolense parasites in the bone marrow, they have been
reported in the arterioles of the bone marrow in cattle [53],
which may link to the marked changes in haemopoiesis
observed during both cattle and rodent infections [49,53,54].
There is generalized micro-vasodilation, most prominent in
the liver and mesentery, as well as lymphocytic infiltration
and accumulation at the corticomedullary junction of the
kidney, liver sinusoids and sinusoids of the pituitary gland
[46]. Despite the abundance of lesions, parasites have never
been observed extravascularly in lymph nodes, kidney, liver
or lung.
3.3. Trypanosoma vivax
Trypanosoma vivax infections are widely known to cause
extensive lesions in virtually all organs and tissues of most live-
stock species. Inflammatory and degenerative lesions have
been described in the heart, spleen, eye, brain, liver, kidney,
lymph nodes [55–62] and reproductive organs [63–66].
Despite some early disagreement on whether T. vivax
could colonize tissues [26,67], parasites have clearly been
observed in ruptured blood vessels [68], in the extravascular
spaces between myocardial fibres, swimming through extra-
vascular fluid (oedema) [58,69], in the aqueous humour of
the eye, in the CNS [57], in the dermis [48], circulating in
the lymphatic vasculature following tsetse inoculation [70]
and in other major organs [60]. More recently, parasites
have been shown by polymerase chain reaction (PCR) in
the reproductive system of both male and female experimen-
tally infected goats [64,66]. It is worth noting that T. vivax
infections may have a milder impact on the skin than T.congolense, an observation supported by lower parasite load
in the dermis (5–10 T. vivax mm22 compared with 150–250
T. congolense mm22), and reduced vascular congestion and
oedema at the chancre [48].
Pathological changes in the heart include generalized
inflammation, with severe mononuclear cell infiltration,
including lymphocytes, plasma cells and macrophages, as
well as myofibre fragmentation and degeneration, or atrophy
myofibres [58,69]. In rodents, multifocal lesions in the heart
were seen to be associated with high trypanosome density in
the ventricular cavities [60]. In the reproductive tract of
goats, lesions include only mild inflammation, testes degener-
ation, multifocal epididymitis and epithelium hyperplasia in
the male [64], and ovarian atrophy and follicle degeneration
in the female [66]. The spleen and liver of outbred mice
show diffuse lesions at 20 days post infection, characterized
by necrotic and haemorrhagic foci in the red pulp of the
spleen, as well as around the portal tracts, the centrilobular
veins and extending into the parenchyma of the liver. These
lesions often associate with extravasated erythrocytes and try-
panosomes [60]. By contrast, extravascular trypanosomes
have never been observed in the kidney, despite evidence of
extensive multifocal tissue damage and immune cell infiltra-
tion of the glomeruli [60]. Similarly to T. brucei infections,
there is damage to the brain, particularly in the cerebellum
and meninges. In rodents, multifocal lesions centred in small
and medium-sized veins are characterized by vascular and
perivascular oedema, accumulation of dysmorphic cells, cell
debris and trypanosomes [60], while in goats trypanosomes
seem to also circulate in the CSF, in the meninges and in the
choroid plexuses of the brain [57].
3.4. Other African trypanosomes: T. equiperdum,
T. evansi, T. suis, T. godfreyi, T. simiae
The T. brucei subspecies group also includes the sexually
transmitted parasite Trypanosoma equiperdum, the cause of
dourine in horses, and the mechanically transmitted parasite
Trypanosoma evansi, the causative agent of surra affecting
mostly camels and horses. T. equiperdum is a tissue parasite,
invading the mucosa of the genitalia in the first phase, and
then progressing to the subcutaneous tissue and internal
reproductive organs. At a later phase, the disease becomes
systemic, with invasion of multiple tissues, especially the per-
ipheral nervous system and CNS [71]. In general, T. evansi
parasites are naturally present in the blood but also localize
extravascularly in tissues including the CNS, the aqueous
humour, heart, lung, liver, kidney and spleen [72–76].
Three less prevalent trypanosomes have been described in
pigs, Trypanosoma suis [77], Trypanosoma godfreyi [78] and
Trypanosoma simiae [79], of which the last is the most patho-
genic. To the best of our knowledge, no description of
tissue tropism for these species exists in the literature.
3.5. Trypanosoma cruzi
Trypanosoma cruzi metacyclic trypomastigotes invade a
variety of cells and differentiate intracellularly into amasti-
gotes. Cell invasion is mediated by parasite-induced
signalling pathways that generally result in the formation of
a membrane-bound vacuole that merges with a recruited
lysosome, preceding parasite escape into the cytosol
Table 2. Summary of the main tissues affected by selected parasitic infections. Adapted from [89]. Figures modiﬁed from Servier
Medical Art, licensed under a Creative Commons Attribution 3.0 Generic License. https://smart.servier.com/.
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6(reviewed in [80]). As amastigotes differentiate into trypo-
mastigotes, they burst out of the host cell into the
bloodstream. However, if the host cell is heavily infected, it
may burst prematurely, releasing amastigotes that can also
be taken up by neighbouring cells. T. cruzi parasites prefer
macrophages because cell invasion is facilitated by phagocy-
tosis [81]. However, they can, and often do, invade somatic
cells in a wide range of tissues, including the lungs, heart,
oesophagus, smooth muscle underlying the digestive tract,
kidney, adrenal glands, pancreas, spleen, liver, skeletal
muscle, bone marrow and adipose tissue [81]. Yet, severe
pathology occurs mostly in the heart and digestive system,
the latter being associated with a severe impairment of the
enteric nervous system [82]. In fact, parasite preference for
the gastrointestinal tract has been recently corroborated by
whole-animal in vivo imaging using bioluminescent T. cruzi
reporter cell lines [83,84].
Overall, T. cruzi tissue distribution is quite complex
because different parasite strains show different tropisms
[81] that can also vary depending on whether it is a single
or mixed infection [85]. For example, in BALB/c and DBA/
2 mice, isolated Col1.7G2 and JG strains both colonize cardi-
omyocytes, but in a mixed infection only the JG straininvades this organ [85]. Heart tropism seems to be influenced
by a peptide motif conserved in all gp85/trans-sialidases,
which interacts with the vascular endothelium with higher
avidity for the heart vasculature than for other organs [86].
Similar to T. brucei, T. cruzi parasites also have a preference
for the adipose tissue, invading adipocytes both in vitro and
in vivo [87,88]. Internalized parasites can modulate adipokine
release, resulting in a unique metabolic profile [87].
Overall, trypanosomes have been associated with the
majority of organs and tissues, reiterating the importance of
tissue tropism in understanding disease pathology, pro-
gression and outcome. On the other hand, it shows a great
diversity in the way the different species of trypanosomes
interact with tissues. From the available literature, it is appar-
ent that T. brucei is a tissue parasite, frequently invading the
parenchyma of multiple organs, whereas T. congolense seems
to be an intravascular parasite, with perhaps some evidence
for vascular sequestration. On the other hand, there is no con-
sensus regarding T. vivax tissue invasion, especially when
deciding whether it actually colonizes the extracellular
matrix of tissue or whether its presence there is due to extra-
vasation from haemorrhagic foci of disease. In the case of
T. cruzi, it seems widely accepted that there is a clear
sequestration
tissues blood tissues blood tissues blood hepatocytes blood brain blood
(a) (b) (c) (e)vascular permeability
PLA
FFA
extravasation (d) transcellular migration transcytosis
Figure 2. Potential mechanisms of tissue tropism in African trypanosome and Plasmodium spp. (a) Sequestration. Trypanosomes can adhere to the endothelial cells
through membrane receptors, potentially sequestering to particular tissues. Sequestration is also done by RBCs infected with Plasmodium spp. (b) Vascular per-
meability. Trypanosomes secrete molecules, including phospholipase A (PLA), that cause lysis of the RBCs, resulting in the release of free fatty acids (FFAs) and other
cell contents to the bloodstream. These molecules increase vascular permeability, which may facilitate migration of parasites through the vascular endothelium into
the underlying tissues. (c) Extravasation. Attachment of trypanosomes to RBCs and/or endothelial cells can cause cell damage, promoting endothelial tissue rupture
and necrosis, followed by extravasation of blood cells and parasites. (d ) Transcellular migration. Plasmodium sporozoites can invade tissues by crossing the endo-
thelial cell layer, in a process called transcellular migration. (e) Transcytosis. Trypanosome invasion of the cerebral parenchyma may occur by transcytosis, in a process
where endothelial cells uptake parasites and, inside a vacuole, they are transported and released in the abluminal side of the vessel, into the brain parenchyma. This
figure was modified from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Generic License. https://smart.servier.com.
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7preference for the heart and digestive systems, and a large
involvement of the autonomous nervous system, which
directly relates to the pathology and symptomatic disease.
In table 2, we summarize the involvement of selected
tissues in a range of parasitic diseases, including trypano-
somes. Interestingly, this highlights that Trypanosoma is the
only genus reported to preferentially invade the heart,
whereas organs such as the liver and the lungs are affected
by a wide range of parasites. The reasons behind trypano-
some colonization of the heart, both intracellularly (T. cruzi)
and extracellularly (African trypanosomes), whereas other
parasites do not, remain largely unknown. A possible expla-
nation might be the strength of the interaction with the
endothelial cell wall that is required compared with that of
other tissues owing to the higher blood pressure in the
heart. In fact, cytoadherence of red blood cells (RBCs)
infected with Plasmodium spp. is dependent not only on the
type of receptors expressed by both the infected RBCs and
the host endothelial cell but also on the sheer force and
blood flow (reviewed in [90–92]).4. Mechanisms of tissue tropism
Tropism is achieved by sophisticated cellular and molecular
mechanisms that depend on the parasite and the affected
organ, which occasionally is host specific. For instance,
parasites in circulation may sequester inside vessels of
specific tissues or invade the extravascular compartment
of those tissues. To enter the stroma and parenchyma of tis-
sues, parasites must pass through the vascular wall, whose
main cellular component is the endothelial cell layer. Cross-
ing of this barrier can be achieved by direct or indirect
interaction between the parasite and the cells, and can
entail from minor changes in vascular permeability to
severe damage. Below we discuss five cellular mechanisms
of tissue tropism: sequestration, alteration of vascular per-
meability, extravasation, transcellular migration and
transcytosis (figure 2).4.1. Sequestration
Sequestration consists of a host–pathogen interaction in
which the pathogen adheres to the endothelial cells lining
the vessels (figure 2a). The pathogen may use this system
regardless of being extra- or intracellular. In fact, this is the
mechanism employed by several Plasmodium spp. and is a
likely scenario in T. congolense infections. Indeed, T. congolense
parasites adhere to the cytoplasmic membrane of endothelial
cells in rats, rabbits, mice and cattle [93,94], and this triggers
the activation of antibody–complement cascades that in turn
cause damage to the endothelial cell layer [95]. In Trypano-
soma infections, endothelial cell adhesion is mediated by the
flagellum, and the occasional appearance of lectin-rich, filo-
podia-like, flagellar protrusions may also help cross-linking
between the flagellum and the sialic acid residues of the
endothelial cell surface membrane [96]. In Plasmodium
falciparum, for which the mechanisms of sequestration are
best characterized, sequestration to the vasculature of specific
organs is mediated by the surface antigen P. falciparum eryth-
rocyte membrane protein 1 (PfEMP1) (reviewed in [91]). This
antigen has multiple domains (e.g. DBL5, CIDR1a,
VAR2CSA, DC4, DC7/13), each of which displays affinity
to different host receptors (e.g. PECAM-1, CD36, CSA,
ICAM-1 and EPCR) present on the surface of vascular endo-
thelial cells (figure 3a) (reviewed in [97,98]). Other
Plasmodium species infecting humans [99–101] and other
mammalian species use some of these receptors for cytoadhe-
sion or sequestration, albeit with different duration and
affinity from that characteristic of P. falciparum [102–105].
4.2. Vascular permeability
Parasite infection may induce changes in the permeability of
the vascular endothelium (figure 2b), allowing parasite diffu-
sion through the cell junctions. For example, African
trypanosomes secrete phospholipase A, which causes haemo-
lysis and platelet aggregation, leading to anaemia and
microthrombus formation [106]. Released fatty acids, and lino-
leic acid in particular during this process, further accentuate the
PECAM-1
(a)  Plasmodium sequestration (b) Trypanosoma crossing of the BBB
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Figure 3. Molecular mechanisms of tissue tropism. (a) Plasmodium sequestration. P. falciparum erythrocyte membrane protein 1 (PfEMP1) is the main mediator of
parasite sequestration. Despite being always the same surface protein, the different expressed domains determine affinity to different tissues. PfEMP1 domains
include DBL-5, CIDR1a, VAR2CSA, DC4 and DC8/13, which bind to endothelial cell receptors PECAM-1, CD36, CSA, ICAM-1 and EPCR, respectively.
(b) Trypanosoma crossing of the BBB. Brain invasion can happen through opening of the tight junctions of the endothelial cells at the BBB. T. brucei, in particular,
secretes brucipain, which acts on G-protein-coupled receptors (GPCRs) that activate phospholipase C (PLC). PLC activation results in increased inositol triphosphate
(IP3) levels that cause an increase in cytosolic calcium (Ca
2þ). Increased calcium levels activate phosphokinase C (PKC), which acts on myosin light chain kinases to
open the tight junctions, thus allowing parasite crossing. The release of interferon g (IFNg) by the parasite is also thought to induce astrocytes to release chemokine
ligand 10 (CXCL-10), which may facilitate parasite movement to the brain parenchyma. This figure was modified from Servier Medical Art, licensed under a Creative
Commons Attribution 3.0 Generic License. https://smart.servier.com/.
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8haemolytic effects of phospholipase A [107,108]. Importantly,
haemolysis-resulting compounds increase vascular per-
meability, which not only leads to oedema but may also
promote parasite migration to extravascular sites [47]
(figure 2a).
In fact, when T. brucei parasites invade the brain, they can
do so through the opening of tight junctions at the endo-
thelial cell layer of the BBB (figure 3b). Here, brucipain
activates G-protein-coupled receptors that activate phospho-
lipase C, leading to the release of inositol 3-phosphate,
which in turn results in the accumulation of cytosolic cal-
cium. The increase in calcium triggers the activation of
phosphokinase C, which acts on myosin light chain kinases
to open the tight junctions that link the endothelial cells at
the BBB [109]. Additionally, a role of interferon g in trypano-
some movement through the brain parenchyma has been
discussed (figure 3b). The interferon g released by the para-
site is thought to act on perivascular astrocytes, triggering
the release of chemokine C–X–X motif ligand 10 (CXCL-
10). This molecule facilitates movement of lymphocytes into
the brain parenchyma and may also facilitate trypanosome
colonization [110,111]. In T. congolense infections, it has
been shown that peritoneal vessels of infected animals are
two times more permeable than those of non-infected ani-
mals [95].4.3. Extravasation
Extravasation happens when parasites leave the vessels
through breaches in a damaged endothelial layer. These
events are associated with the establishment of haemorrhagic
foci, as observed in T. vivax infections (figure 2c) [60]. In
experimentally infected sheep, approximately 40% of T.
vivax parasites have been shown to adhere to RBCs through
both the flagellum and the body [112]. This adhesion,
mediated by sialic acid receptors, and the secretion of biologi-
cally active trypanosome substances result in generalizedmembrane damage and increased erythrophagocytosis
[113,114]. Furthermore, the formation of RBC–parasite–
leucocyte thrombi accentuates anaemia and compromises
metabolic exchanges at the vessel–tissue interface, thus
contributing to endothelial cell necrosis [112].4.4. Transcellular migration
Transcellular migration (figure 2d) consists of the crossing
through a cell to reach another one. Whether Trypanosoma
species employ thismechanism during host invasion is unclear;
however, this is the mechanism employed by Plasmodium spp.
sporozoites during hepatocyte invasion. Sporozoites cross the
endothelial cell and transmigrate through various hepatocytes
before invading one. In the hepatocyte that sporozoites finally
invade, asexual replication by schizogony occurs within a para-
sitophorous vacuolarmembrane [115]. The coordinated steps of
transmigration, invasion and parasitophorous vacuolar mem-
brane formation depend on specific interactions between the
host and parasite proteins (reviewed in [116]). If hepatocyte
invasion and development succeed, the liver stage of infection
culminates with Plasmodium egressing from the liver via
merosomes [117], release of merozoites and invasion of RBCs
already back in the capillaries [118], giving rise to the
symptomatic stages of infection (blood stage).4.5. Transcytosis
The uptake of several macromolecules can happen through
the crossing of the endothelial cells via a vacuole, in a mech-
anism named transcytosis. This happens often at the BBB to
move molecules or pathogens between the cerebral micro-
capillaries and the brain parenchyma (figure 2e). For
example, it has been described as themechanismofCronobacter
sakazakii crossing of the BBBand the intestinal epithelium [119],
as well as Listeria monocytogenes crossing the intestinal goblet
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9cells [120]. It has not been indisputably shown whether trypa-
nosome parasites can use this mechanism to invade the brain.
Besides these multi-player cellular mechanisms, specific
genes have been described to be crucial for tropism, such as
var genes in P. falciparum discussed above, d-amastins in
T. cruzi and Leishmania, and the A2 gene family and
Ld28.0340 in Leishmania donovani. The A2 gene family and
Ld28.0340 [121] have both been found to contribute to viscer-
alization of leishmaniasis, namely by increasing the ability of
parasites to survive in the spleen and liver of infected mice
[122–124]. A cell tropism example is that of d-amastins,
which are surface proteins specific to Trypanosomatids
with intracellular life cycle stages (i.e. T. cruzi and Leishmania)
and which are essential for parasite survival in the host cell
(i.e. macrophages). Indeed, RNAi knockdown of d-amastin
in Leishmania braziliensis causes defects in the membrane con-
tact between the parasitophorous vacuole of the host
macrophage and intracellular amastigotes [125].900365. Advantages of tissue tropism for the
parasite
Onceparasitesovercome the challengeof enteringandadjusting
to the tissue microenvironment, residing in these extravascular
spaces may provide a selective advantage. Here, we discuss a
few examples of how parasites may benefit from establishing
tissue reservoirs, namely in the context of progressing
to a chronic infection to reduce virulence and of enhancing
transmission, immune evasion and resistance to treatment.
5.1. Infection chronicity and reduced virulence
Residing in tissues may reduce disease burden if parasites
become latent or more slow growing, which would then pro-
long host survival and ultimately favour disease transmission
and life cycle completion [126].
Trypanosoma congolense cattle infections are typically
characterized by acute and chronic phases. The acute phase
consists of two to four parasitaemia peaks (up to 108 parasites
per millilitre of blood in experimental rodent models and 107
in livestock) that usually last 1–3 days, followed by a continu-
ous phase of fever of up to 30 days. After this period, body
temperature returns to normal and parasitaemia is only spor-
adically detectable in short peaks. Despite the apparent
recovery, it is during this chronic state that animals become
weaker, more emaciated and prostrated [45]. While parasite
peaks may be detected often in the blood, the total number
of parasites is not as high as in the early phases of the disease.
The characteristics of the T. congolense chronic stage are diffi-
cult to reconcile because while the host’s natural resistance
increases and the number of parasites reduces, overt pathol-
ogy is more evident, accompanied by clinical signs. The
causes of such progression are not clear. It could be a conse-
quence of the severe anaemia, although if anaemia were
induced by the parasite’s presence in the blood then it
would return to normal upon parasite clearance, which it
does not. It could be an immunological or anaphylactic reac-
tion to the high load of parasite contents resulting from
parasite clearance. However, again this would be more
marked during the acute rather than the chronic stage,
unless it was due to progressive sensitization to parasite anti-
gens [45]. It could also result from the direct intervention ofparasites outside the main blood vessels, i.e. in the tissues
[45]. In fact, it has been suggested that parasites in tissue
foci may actually be the cause of disease signs and pathology
[127]. In this case, the sporadic low parasitaemia peaks reflect
an overspill from tissue-resident parasite populations. This
theory is supported by two main observations: first, the fact
that both drug prophylaxis and suboptimal drug treatment
are efficient at preventing the acute phase of the disease but
are not curative and disease becomes chronic; and second,
that anti-trypanosome serum antibody levels remain high
throughout the chronic stage, despite the extremely low
parasite load in the blood [127].
When patients with chronic Chagas disease do not or have
not yet developed pathology, disease is considered to be in an
indeterminate stage, lasting 10 years to life. At this point, para-
sites circulate in the blood at microscopically undetectable
levels and can be transmitted to biting flies, vertically and
horizontally via blood transfusions and the oral–faecal route
(reviewed in [128]). Similar to African trypanosomes, it is
possible that T. cruzi parasites hidden inside host cells may
at times repopulate the blood, both enhancing transmission
potential and increasing disease progression.
Another interesting example of how tissue tropism can be
exploited by parasites other than trypanosomes to maximize
infection potential is the latency phenomenon employed by
some Plasmodium species. In humans, latency is largely
caused by P. vivax and Plasmodium ovale, and occurs in the
liver, in stages called hypnozoites. The relapses caused by
hypnozoites display a high periodicity, with the relapse inter-
vals being short and frequent in tropical regions, and more
temporally spread in temperate regions with obligate winters
[129,130]. Various hypotheses exist on the potential benefit of
the dormancy mechanism and corresponding relapses,
including their being advantageous during intra-host compe-
tition with other Plasmodium species and that they could
allow simultaneous feeding of different Plasmodium strains
to mosquito vectors, contributing to the high genetic diver-
sity even in areas of low seasonal transmission (reviewed
in [131]).
5.2. Enhanced transmission
Residing in the skin, for example, could allow parasites to
expand transmission sites and consequently expedite deliv-
ery to the next host [12,13]. T. brucei, T. congolense and T.
vivax parasites colonize the skin early in infection, shortly
after the bite by the tsetse. All three species have been
reported to proliferate in skin tissue, in both the dermis and
the hypodermis (including in the connective and adipose tis-
sues), continuing to do so after blood invasion. For T. brucei, it
was further shown that skin trypanosomes actively contrib-
ute to infection [12,13]. Currently, there is no reason to
assume T. congolense and T. vivax would behave differently.
If more parasites are accessible in the skin, the probability
of them being ingested by flies increases. Therefore, skin trop-
ism independent of bloodstream proliferation is
advantageous for the parasite, maximizing the transmission
potential of a single host.
Tropism to reproductive organs may contribute to
sexual transmission, as is the case with T. equiperdum and
T. brucei gambiense, where, although seemingly rare in vector-
borne trypanosomes, vertical and horizontal transmission has
been reported [30]. It is worth noting that infected animals
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10were aparasitaemic by both PCR and loop-mediated isothermal
amplification (LAMP),despitedetectionofparasites in the repro-
ductive organs by bioluminescence imaging [30]. While the
reproductive system reservoirs are unlikely to be accessible by
the tsetse, they certainly enhance vertical and horizontal
transmission and may provide a source of parasites for blood
re-invasion. In fact, the potential for re-entering the circulation
(and thus becoming accessible to tsetse transmission) is
common to all tissues. As therapy for both animalAfrican trypa-
nosomiasis and human African trypanosomiasis (HAT) is
directed towards either microscopy-positive or symptomatic
individuals, a proportion of infected, yet asymptomatic and
aparasitaemic, animals and humans may remain a source of
transmission. Indeed, recently, the impact of asymptomatic car-
riage of skin-dwelling, transmissible T. brucei gambiense in HAT
transmissionwasassessedandshown tobea reasonableobstacle
for sleeping sickness elimination [14].
5.3. Immune evasion
The peculiarities of the parasite-specific immune response
and the compositional differences of tissue-resident
immune cells mean that particular tissues might be less effi-
cient in clearing infection. Therefore, we could hypothesize
that some extravascular spaces might be a better environment
for parasite survival than the blood. In fact, the selection of
host cells for immune avoidance is observed throughout Plas-
modium infections. For example, in the liver, T-cell activation
promotes tolerance rather than inducing priming [132–134],
thus increasing the chances of parasite survival during pre-
erythrocytic stages of infection. Despite cytotoxic T cells
having the capacity to eliminate infected hepatocytes, this
mechanism alone is insufficient to ensure suppression of
infection for reasons that are as yet unclear, but that are
potentially linked to parasite exploitation of immune toler-
ance and fast parasite replication (reviewed in [135]).
Likewise, a large number of helminths colonize the eye,
regarded as a more protective environment against immune
responses [136], even though these parasitic infections do
eventually cause inflammation [137]. For example, microfilar-
iae of Onchocerca volvulus, the cause of river blindness in
37 million people [138], migrate to the eye from the
subcutaneous tissue.
In the case of African trypanosomes, parasite evasion to
extravascular spaces could simply be a strategy to avoid the
massive humoral responses in the bloodstream [139], allow-
ing for periodical blood repopulation. In bloodstream
infections, the host is well documented to mount a cellular
and humoral immune response against the variant surface
glycoproteins (VSGs) expressed by the parasites. VSGs are
highly immunogenic proteins that provoke an extensive anti-
body response by the host. This potent and systemic antibody
response is thought to be directed against the predominant
VSG expressed by bloodstream parasites. The existence of a
very small proportion of parasites expressing minor VSG var-
iants results in the characteristic ‘waves of parasitaemia’, and,
thus, the recurrent nature of the disease. However, trypano-
some populations from different niches in the same animal
may not express the same VSG. This is supported by very
weak anti-serum cross-reaction between populations of
different body compartments of both T. vivax and T. brucei
gambiense [57,140,141]. If parasites in different tissues
expressed different VSGs, the systemic antibody responsemight not be effective. Thus, the potential VSG heterogeneity
in different body compartments could contribute to subopti-
mal antibody-based immunity and accelerate host immune
exhaustion. Furthermore, if these parasites were in sufficient
numbers (like they are in the adipose tissue of T. brucei-
infected rodents) and in non-immune-privileged sites, they
themselves might trigger a different antibody response,
which would compete in lymphoid organ resources, thus
potentially also precipitating immune exhaustion.
Links between antigenic surface proteins and tissue
tropism have been reported in other parasites. For example,
the P. falciparum PfEMP1 ligand, encoded by the antigenically
variable var genes, has domains with different avidities to the
endothelial cells of different tissues. For example, sequestra-
tion to the placenta is mediated by binding of the
VAR2CSA protein to chondroitin sulfate A (CSA) in the pla-
cental endothelium [142]. Accumulation in the placenta is
thought to be one of the ways the parasite uses to circumvent
host immunity, with up to 90% of parasite stages localizing to
the placental intervillous space, and not other organs [143].
Parasites that specifically bind to VAR2CSA fail to cause
pathology if injected into men or children, despite antibodies
against these variants being present in these hosts [144]. Sur-
face antigens of infected erythrocytes are immunologically
distinct from other variant surface antigens, and are the
main targets of immunoglobulin G mediating protective
immunity. Interestingly, the CSA specificity is such that per-
ipheral parasitaemia is often resolved within a few days of
delivery in women living in areas of intense P. falciparum
transmission [145]. Altogether, antibody recognition of pla-
cental infected erythrocytes is highly dependent on the
level of immunity, the time of pregnancy and the level of
malaria prevalence in different settings.
5.4. Treatment failure
Tissue tropism, particularly in the brain and the adipose
tissue, has long been recognized as a potential explanation
for drug failure and treatment relapse owing to their lower
permeability to drugs. The BBB prevents the entry of many
drugs, including diminazenes, into the brain, thus allowing
survival of parasites during chemotherapy. This mechanism
is well established for T. brucei infections [146–148]. White-
law et al. [57] showed relapses of two T. vivax infections in
goats six weeks after treatment with diminazene aceturate,
despite undetectable parasitaemia in the blood. However, it
is possible that parasites accumulating in tissues other than
the CNS may also be less accessible by drugs, particularly
in immune-privileged sites, such as the eyes, testicles, pla-
centa and, to some degree, the adipose tissue. In fact,
owing to its high lipid content and low perfusion, the adipose
tissue is known to be impermeable to drugs in general but
especially to those that are hydrophilic. These characteristics
could be responsible for the observed inefficiency in field
treatments and justify the observed relapses in African trypa-
nosomiasis-treated patients [149,150]. In fact, despite
treatment, T. cruzi parasites survive in the adipose tissue in
a cryptic state for a year in mice, and decades in humans,
before recrudescence [87,88]. Similarly, work on rodent
models of malaria have shown that, while drug treatment
with some antimalarials efficiently clears peripheral ongoing
erythrocyte-stage infections, it fails to clear parasites in
erythropoietic organs [151]. The implications of these
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11observations for Plasmodium transmission, therapeutics and
cure assessment are significant. In humans, the interplay
between haematopoietic organs and parasite clearance upon
antimalarial drug treatment has been recognized as an
altogether key field (reviewed in [152]). Moreover, trans-
mission-stage survival in erythropoietic niches, even in
view of antimalarial drug treatment, has been reported in
several autopsy case studies in humans [153–156].
Treatment failure due to specific tissue tropism is an issue
in other parasitic diseases, such as toxoplasmosis. T. gondii
bradyzoites can remain hidden in cysts inside a variety of
brain cells, including neurons and astrocytes, and cause a
chronic disease, characterized by changes in neuronal archi-
tecture, neurochemistry and behaviour. These cysts are
refractory to drugs and the reason for lifelong persistence of
the parasite in the host. Interestingly, although it was pre-
viously thought to be a dormant state, bradyzoites inside
cysts have recently been shown to be replicative [157].
Whereas tissue tropism is probably not a result of selec-
tion by therapeutics, in multiple cases, the heterogeneous
distribution of drugs through different tissues confers an
additional advantage for parasites in particular niches.6. Tissue tropism and organ-specific
pathology
In the arms race between the pathogen and the host, the host
tries to fight back the assaults of the parasite. The infection
poses a challenge for the host as parasite evasion hampers
disease control and forces the host to mount a chronic inflam-
matory response. Host alterations can be very extensive
during parasitic infections. The most widespread alteration
in trypanosome infections is parasite-driven, immune-
mediated tissue damage. In most tissues, a localized
immune response is triggered upon parasite presence,
which persists throughout the chronic phase (when present),
resulting in tissue damage. For example, Carvalho et al. [39]
showed immune cell infiltration and tissue damage in the
testes of T. brucei-infected mice as disease progresses.
A pathogenic inflammatory immune response is also present
in the liver, being positively mediated by macrophage
migration inhibitory factors, which are important regulators
of innate immunity [158]. Moreover, in African trypanoso-
miasis, when parasites reach the CNS, a strong
inflammatory response is triggered, resulting in organ-
specific pathology, with development of the previously men-
tioned severe neurological signs that can culminate in death.
Cerebral trypanosomiasis has been extensively reviewed by
others [111,159,160]; therefore, below, we discuss in more
detail other examples of immune-mediated tissue damage.
6.1. Trypanosoma vivax haemorrhagic syndrome
Sporadically, in East Africa, T. vivax infections may progress to
severe disease, called haemorrhagic syndrome. It is character-
ized by profound anaemia and haemorrhages of the
gastrointestinal and respiratory tracts, liver, spleen, kidneys,
heart and bladder, concomitant with widespread parasite
infiltration and sporadic ulceration. Unlike non-haemorrhagic
disease, lymph nodes are normal in size, but they show para-
site accumulation in vessels and haemorrhages throughout the
tissue. Skeletal muscle may display haematomas, consistentwith anaerobic tissue injury, but lacking gas accumulation
[7]. Further investigations of these severe, acute cases have
revealed increased levels of fibrinogen and fibrin degradation
products, diffuse intravascular coagulation, reduced numbers
of platelets [161] and the production of autoantibodies against
erythrocytes and platelets [162]. Moreover, histological ana-
lyses revealed fibrin clots in the ventricles of the brain and
blood clots in lymphatic vessels [163]. The causes of such an
extreme phenotype remain unknown. Although previously
regarded as likely candidates, autoantibody production only
peaks three to four weeks after infection, when haemorrhagic
lesions are already established and animals die shortly after
[164]. Similarly, the release of biologically active molecules
that could induce cell membrane degradation, including neur-
aminidase, phospholipases and free fatty acids, has been
considered as a potential cause of the lesions [164], but these
are also released during other trypanosome infections without
the extreme phenotype. Alternative explanations, albeit non-
exclusive, include the negative effects of decreased platelet
counts in vascular permeability and the clotting cascade
[164]; histone-mediated damage, as observed in sepsis
(reviewed in [165]); and the damage induced by
trypanosomes crossing the vascular endothelium to colonize
tissues and extravascular spaces [68].
6.2. Chagasic megasyndromes
During chronic disease, 20–30% of infected individuals
develop irreversible pathology of the heart (94.5%) or diges-
tive system (4.5%). Patients with the latter condition exhibit
digestive megasyndromes characterized by megaoesophagus
and megacolon [166], where lesions are caused simul-
taneously by the parasite and the host. Specifically,
digestive tract lesions are attributed to both parasite persist-
ence in the cells of these organs, resulting in cell burst and
associated inflammation, and an autoimmune reaction in
which the parasite modulates lymphocytes to reject
parasite-free cells and trigger host cell destruction [166].
It is worth noting that, even when parasites are relatively
absent from an organ, lesions via systemic responses may still
be extensive. A good example is the metabolic distress syn-
drome sometimes observed in P. falciparum infections [167].
Renal dysfunction during malaria-associated acute kidney
injury causes accumulationof acidsnormallyexcretedormetab-
olized by the kidneys. This metabolic acidosis associates with
increased vascular leakage in multiple organs including the
kidney, and renal failure. Considering the large immunological
impairment characteristic of trypanosomiasis, this might be rel-
evant in T. congolense and T. vivax infections if future studies of
tropism reveal that particular tissues are refractory to invasion
or sequestration, despite the existence of lesions.
There can be parasite-driven host alterations that are unre-
lated to the immune response, but associated with colonization
of a specific organ. Here, we will discuss two examples: the cir-
cadian disorder observed in T. brucei infections, and the
cachexia characteristic of all African trypanosome infections.
6.3. Host circadian disorder
When T. brucei parasites invade the brain, they cause a sleep
disorder rendering altered sleep/wake cycles.
The underlying causes of this disorder were shown for
the first time in infected mice, which showed not only
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12alterations in their circadian sleep but also altered temperate
regulation and feeding patterns. Infection resulted in
advanced circadian rhythms exhibiting atypical activity
during the resting phase. This behavioural pattern was
shown to be due to a shortening in their circadian activity
period and induced specifically by the presence of T. brucei
that might interact directly or indirectly, via secreted mol-
ecules, with the host cells [168]. Upon parasite clearance,
the sleep/wake cycle returns to normal, which, coupled
with the observation that patients with terminal sleeping
sickness do not show neuro-degeneration [111,169], indicates
that it is the presence of T. brucei parasites and not the effect
on the neuronal tissue that causes the circadian disturbance
characteristic of sleeping sickness [168]. How this disorder
may benefit the parasite and/or host remains a mystery.
However, it is known that T. brucei parasites modulate their
gene expression according to the time of the day, which has
consequences in their resistance to external challenges. For
example, sensitivity to oxidative stress and to drugs (e.g. sur-
amin) is different throughout the day [170], which may be an
important factor when designing drug treatment plans.
6.4. Cachexia
African trypanosomiasis is a wasting disease, characterized
by signs of anorexia, emaciation, prostration and cachexia
affecting all symptomatic hosts [49,71,171–173]. Cachexia is
a metabolic syndrome associated with an underlying disease,
characterized by loss of fat and muscle. It is typically more
pronounced during the chronic phase of disease, but
weight loss occurs from early stages of infection. In exper-
imental mice models, loss of fat has been estimated at 43%
during infection [174]. It usually results from the presence
of pro-inflammatory immune mediators and the activation
of biochemical pathways that increase metabolism rate, lipo-
lysis and muscle breakdown. In fact, in horses naturally
infected with T. evansi, significantly increased plasma trigly-
cerides and cholesterol levels, particularly of low-density
lipoprotein, have been reported [175]. A similar pattern has
been observed in goats experimentally infected with
T. vivax; specifically, an increase in non-esterified fatty acids
circulating in the bloodstream 14 days post infection was
shown [176]. Together, these studies suggest increased lipoly-
sis during infection. Yet, it remains undetermined whether
this is only a consequence of the immune dysregulation
observed from early stages of infection, particularly due to
the VSG-induced, high levels of tumour necrosis factor a
[177], a result of appetite loss, or whether it also results
from the direct action of the parasite; for example, due to
the colonization and metabolic adjustment of T. brucei in
the adipose tissue [31]. Nonetheless, cachexia is a major
cause of morbidity among infected hosts, a large constraint
for African agricultural development and a major source of
economic loss in the animal husbandry industry in Africa
and South America, which may relate to the parasite’s ability
to thrive in lipid-rich environments.7. Future perspectives for tissue tropism
research
As the literature on livestock trypanosomiasis is old, scant and
somewhat contradictory, it is clear that a systematic analysis ofTrypanosoma tissue distribution is long due. Recent discoveries
of T. brucei tropism to the skin and adipose tissue have revita-
lized the study of tissue tropism in parasitic diseases.
Tissue tropism impacts our knowledge of host–pathogen
interactions, thus raising a number of new questions.
— As we see T. brucei re-wiring its gene expression in par-
ticular body niches, such as the adipose tissue [31], we
wonder about its effect on parasite fitness, and whether
this applies to other organs as well. We should also inves-
tigate how other Trypanosoma species approach different
environments.
— Would trypanosome motility, reported as critical for the
establishment and maintenance of a bloodstream infec-
tion [178], impact extravascular tissue colonization in
the same way?
— Do trypanosomes in different tissues express different
VSG profiles like Plasmodium expresses different var
genes? If so, what are the immunological consequences
for the host?
— Does the parasite population in one host work as an
‘organism’, such that, for example, parasites in one
organ could induce changes in the host that benefit
parasites in another organ? It has been demonstrated
that many parasites sense their counterparts by
quorum-sensing mechanisms, indicating the presence
of mechanisms to sense and react to nearby popu-
lation density. For example, in the bloodstream,
T. brucei differentiation from replicative, slender
forms to transmissible, stumpy forms is mediated by
quorum sensing [179].
Answering these questions will improve our chances of
reducing the burden of parasitic diseases. Fortunately, we
have an array of methodologies that can help us answer
these questions and many more. The ‘omics technologies
provide an opportunity to generate large datasets that
advance our understanding of host and parasite biology,
and host–parasite interactions, from a wider perspective.
Additionally, parasite genetic manipulation combined
with microscopy techniques bring excellent prospects to
the study of infection dynamics inside the mammalian
host [180]. For example, in the past, intravital microscopy
was performed on T. brucei-infected mice to study lympho-
cyte response in the brain [181]. This technique, combined
with fluorescent-labelled parasites [182], may be useful to
study migration patterns and social behaviours. On a
more detailed level, complex tissue organoids and three-
dimensional cultures may help us understand the molecu-
lar interactions underlying tissue tropism. Genetic screens
can be combined with all the previous techniques to ident-
ify genes essential for establishment, invasion and/or
sequestration to tissues. In this area, we can make use of
multiple tools, including RNA interference (RNAi) target
sequencing (RIT-seq) for high-throughput phenotyping
[183] and CRISPR–Cas9 for multi-copy gene family target-
ing [184,185], the latter being particularly relevant for
Trypanosomatids, given the abundance of parasite-specific
gene family expansions observed in their genome
sequences [186,187].
Besides the biological aspects of tissue tropism, develop-
ment in this area may have a direct impact on disease
progression, clinical treatment and transmission.
royalsocietypublishing.org/journal/rsob
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13— Who benefits from specific tissue tropisms? Is it the host,
the parasite or both? Understanding this benefit can bring
us closer to finding ways to target disease. We would
expect factors such as parasite transmission, parasite repli-
cation and reduced virulence (such that the host is kept
alive for a long time) to be affected by tropism, probably
by playing an important selective pressure during host–
parasite coevolution.
— What is the impact of tissue tropism in clinical treatment?
Are parasites in certain tissues inefficiently eliminated by
certain drugs? As we have shown in this review, this
subject has begun to be tackled in multiple parasite
research fields, including trypanosomes [28,88], Plasmo-
dium (reviewed in [152]) and Toxoplasma (reviewed in
[188]), but still needs further investigation.As our efforts shift towards this field, we will start to truly
appreciate the impact of tissue reservoirs on treatment success,
transmission control strategies and vaccine development.
Hopefully, it will get us closer to trypanosomiasis elimination
and eradication.
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